Linnaeus Therapeutics is a development stage biotech company engaged in the identification and development of small molecule agents for the treatment of cancer.

Linnaeus Therapeutics

Linnaeus Therapeutics, Inc. | 580 followers on LinkedIn. Privately held biotech developing drugs for cancer | Linnaeus Therapeutics, Inc. is a privately held clinical-stage biopharmaceutical company focused on the development and commercialization of novel small molecule oncology therapeutics that target G protein-coupled receptors. The company was formed and launched in partnership with the UPstart incubator at the University of Pennsylvania’s Penn Center for Innovation (PCI).

COO at Linnaeus Therapeutics

Tina Garyantes

Executive Director of PCI Ventures

Michael Poisel

Patrick Mooney

Cofounder & CSO at Linnaeus Therapeutics

Christopher Natale, PhD

Linnaeus Therapeutics, Inc.

We've recently identified attempts to impersonate Linnaeus through fake letterhead and domain names. We take such matters very seriously and have taken action against these individuals.

LINN

COM:LINNAEUSTX

Linnaeus Therapeutics

Analysis Not Available